http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020034114-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdd4d9842010fb14ed2a32c5850858dd
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D263-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D263-58
filingDate 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80b469c13602eeaae7e06a6be51c4c3a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50dca39447bdcf31b22e413a430feee8
publicationDate 2020-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2020034114-A1
titleOfInvention CRYSTAL FORM OF PPARĪ± AGONIST, PREPARATION METHOD THEREFOR AND USE THEREOF
abstract Provided are crystal form I and crystal form II of (R)-2-[3-[[N-(benzoxazole-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl)phenoxy]butyric acid. The above-mentioned two crystal forms have a good illumination stability, a good high-temperature stability and a good high-humidity stability.
priorityDate 2018-08-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1854779-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1852426-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8857
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408497310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397769
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487106
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID98527
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID460178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID19016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8058
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID397671
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281993
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450152145
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID557037
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5468
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396423
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22114717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373928
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393346
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538408
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25664

Total number of triples: 57.